Time-dependent retinal ganglion cell loss, microglial activation and blood-retina-barrier tightness in an acute model of ocular hypertension

Glaucoma is a group of neurodegenerative diseases characterized by the progressive loss of retinal ganglion cells (RGCs) and their axons, and is the second leading cause of blindness worldwide. Elevated intraocular pressure is a well known risk factor for the development of glaucomatous optic neurop...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental eye research 2015-07, Vol.136, p.59-71
Hauptverfasser: Trost, A., Motloch, K., Bruckner, D., Schroedl, F., Bogner, B., Kaser-Eichberger, A., Runge, C., Strohmaier, C., Klein, B., Aigner, L., Reitsamer, H.A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 71
container_issue
container_start_page 59
container_title Experimental eye research
container_volume 136
creator Trost, A.
Motloch, K.
Bruckner, D.
Schroedl, F.
Bogner, B.
Kaser-Eichberger, A.
Runge, C.
Strohmaier, C.
Klein, B.
Aigner, L.
Reitsamer, H.A.
description Glaucoma is a group of neurodegenerative diseases characterized by the progressive loss of retinal ganglion cells (RGCs) and their axons, and is the second leading cause of blindness worldwide. Elevated intraocular pressure is a well known risk factor for the development of glaucomatous optic neuropathy and pharmacological or surgical lowering of intraocular pressure represents a standard procedure in glaucoma treatment. However, the treatment options are limited and although lowering of intraocular pressure impedes disease progression, glaucoma cannot be cured by the currently available therapy concepts. In an acute short-term ocular hypertension model in rat, we characterize RGC loss, but also microglial cell activation and vascular alterations of the retina at certain time points. The combination of these three parameters might facilitate a better evaluation of the disease progression, and could further serve as a new model to test novel treatment strategies at certain time points. Acute ocular hypertension (OHT) was induced by the injection of magnetic microbeads into the rat anterior chamber angle (n = 22) with magnetic position control, leading to constant elevation of IOP. At certain time points post injection (4d, 7d, 10d, 14d and 21d), RGC loss, microglial activation, and microvascular pericyte (PC) coverage was analyzed using immunohistochemistry with corresponding specific markers (Brn3a, Iba1, NG2). Additionally, the tightness of the retinal vasculature was determined via injections of Texas Red labeled dextran (10 kDa) and subsequently analyzed for vascular leakage. For documentation, confocal laser-scanning microscopy was used, followed by cell counts, capillary length measurements and morphological and statistical analysis. The injection of magnetic microbeads led to a progressive loss of RGCs at the five time points investigated (20.07%, 29.52%, 41.80%, 61.40% and 76.57%). Microglial cells increased in number and displayed an activated morphology, as revealed by Iba1-positive cell number (150.23%, 175%, 429.25%,486.72% and 544.78%) and particle size analysis (205.49%, 203.37%, 412.84%, 333.37% and 299.77%) compared to contralateral control eyes. Pericyte coverage (NG2-positive PC/mm) displayed a significant reduction after 7d of OHT in central, and after 7d and 10d in peripheral retina. Despite these alterations, the tightness of the retinal vasculature remained unaltered at 14 and 21 days after OHT induction. While vascular tightness was u
doi_str_mv 10.1016/j.exer.2015.05.010
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1688003711</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S001448351500158X</els_id><sourcerecordid>1688003711</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-5f9616ed4f9f5550f19adf5ff42ca943e7e9771ff6aaf0b9fa1c2de974efb4873</originalsourceid><addsrcrecordid>eNp9UctqHDEQFCEhXjv5gRyCjjl41tKMpNkBX4LxCwy-OGehkVprLRppI2mM_Q_-6GhYO0dDQ0N3VUFVIfSDkjUlVJzt1vAMad0SytekDiWf0IqSQTSEkP4zWhFCWcM2HT9Cxznv6rVjPfuKjlpRX7wVK_T64CZoDOwhGAgFJyguKI-3Kmy9iwFr8B77mPMpnpxOsV7rW-ninlRZACoYPPoYTXPgNqNKyUHCxW0fS4CcsVtQlTMXwFM04HG0OOrZq4QfX_aQCoRctb6hL1b5DN_f9gn6c3X5cHHT3N1f3178vmt0x0VpuB0EFWCYHSznnFg6KGO5tazVamAd9DD0PbVWKGXJOFhFdWvqjYEd2abvTtCvg-4-xb8z5CInlxejKkCcs6Ris6lZ9ZRWaHuAVus5J7Byn9yk0oukRC4tyJ1cWpBLC5LUoaSSfr7pz-ME5j_lPfYKOD8AoLp8qmHJrB0EDcYl0EWa6D7S_wc0mZyq</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1688003711</pqid></control><display><type>article</type><title>Time-dependent retinal ganglion cell loss, microglial activation and blood-retina-barrier tightness in an acute model of ocular hypertension</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Trost, A. ; Motloch, K. ; Bruckner, D. ; Schroedl, F. ; Bogner, B. ; Kaser-Eichberger, A. ; Runge, C. ; Strohmaier, C. ; Klein, B. ; Aigner, L. ; Reitsamer, H.A.</creator><creatorcontrib>Trost, A. ; Motloch, K. ; Bruckner, D. ; Schroedl, F. ; Bogner, B. ; Kaser-Eichberger, A. ; Runge, C. ; Strohmaier, C. ; Klein, B. ; Aigner, L. ; Reitsamer, H.A.</creatorcontrib><description>Glaucoma is a group of neurodegenerative diseases characterized by the progressive loss of retinal ganglion cells (RGCs) and their axons, and is the second leading cause of blindness worldwide. Elevated intraocular pressure is a well known risk factor for the development of glaucomatous optic neuropathy and pharmacological or surgical lowering of intraocular pressure represents a standard procedure in glaucoma treatment. However, the treatment options are limited and although lowering of intraocular pressure impedes disease progression, glaucoma cannot be cured by the currently available therapy concepts. In an acute short-term ocular hypertension model in rat, we characterize RGC loss, but also microglial cell activation and vascular alterations of the retina at certain time points. The combination of these three parameters might facilitate a better evaluation of the disease progression, and could further serve as a new model to test novel treatment strategies at certain time points. Acute ocular hypertension (OHT) was induced by the injection of magnetic microbeads into the rat anterior chamber angle (n = 22) with magnetic position control, leading to constant elevation of IOP. At certain time points post injection (4d, 7d, 10d, 14d and 21d), RGC loss, microglial activation, and microvascular pericyte (PC) coverage was analyzed using immunohistochemistry with corresponding specific markers (Brn3a, Iba1, NG2). Additionally, the tightness of the retinal vasculature was determined via injections of Texas Red labeled dextran (10 kDa) and subsequently analyzed for vascular leakage. For documentation, confocal laser-scanning microscopy was used, followed by cell counts, capillary length measurements and morphological and statistical analysis. The injection of magnetic microbeads led to a progressive loss of RGCs at the five time points investigated (20.07%, 29.52%, 41.80%, 61.40% and 76.57%). Microglial cells increased in number and displayed an activated morphology, as revealed by Iba1-positive cell number (150.23%, 175%, 429.25%,486.72% and 544.78%) and particle size analysis (205.49%, 203.37%, 412.84%, 333.37% and 299.77%) compared to contralateral control eyes. Pericyte coverage (NG2-positive PC/mm) displayed a significant reduction after 7d of OHT in central, and after 7d and 10d in peripheral retina. Despite these alterations, the tightness of the retinal vasculature remained unaltered at 14 and 21 days after OHT induction. While vascular tightness was unchanged in the course of OHT, a progressive loss of RGCs and activation of microglial cells was detected. Since a significant loss in RGCs was observed already at day 4 of experimental glaucoma, and since activated microglia peaked at day 10, we determined a time frame of 7–14 days after MB injection as potential optimum to study glaucoma mechanisms in this model. •Chronological pathological changes in an acute model of ocular hypertension.•Evaluation of RGC degeneration and microglial activation at 5 time points.•Evaluation of retinal vascular alterations in the course of MB-induced OHT.•Definition of an optimal time frame (7–14d) to employ experimental interventions.</description><identifier>ISSN: 0014-4835</identifier><identifier>EISSN: 1096-0007</identifier><identifier>DOI: 10.1016/j.exer.2015.05.010</identifier><identifier>PMID: 26001526</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Acute Disease ; Animals ; Antigens - metabolism ; Biomarkers - metabolism ; Blood-Retinal Barrier - metabolism ; Blood-Retinal Barrier - pathology ; Calcium-Binding Proteins - metabolism ; Disease Models, Animal ; Experimental glaucoma ; Female ; Fluorescent Antibody Technique, Indirect ; Intraocular Pressure ; Male ; Microfilament Proteins - metabolism ; Microglia ; Microglia - metabolism ; Microglia - pathology ; Microscopy, Confocal ; Ocular hypertension ; Ocular Hypertension - etiology ; Ocular Hypertension - metabolism ; Ocular Hypertension - pathology ; Pericytes ; Proteoglycans - metabolism ; Rats ; Rats, Inbred BN ; Real-Time Polymerase Chain Reaction ; Retinal ganglion cells ; Retinal Ganglion Cells - metabolism ; Retinal Ganglion Cells - pathology ; Time Factors ; Transcription Factor Brn-3A - metabolism</subject><ispartof>Experimental eye research, 2015-07, Vol.136, p.59-71</ispartof><rights>2015</rights><rights>Copyright © 2015. Published by Elsevier Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-5f9616ed4f9f5550f19adf5ff42ca943e7e9771ff6aaf0b9fa1c2de974efb4873</citedby><cites>FETCH-LOGICAL-c356t-5f9616ed4f9f5550f19adf5ff42ca943e7e9771ff6aaf0b9fa1c2de974efb4873</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S001448351500158X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26001526$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Trost, A.</creatorcontrib><creatorcontrib>Motloch, K.</creatorcontrib><creatorcontrib>Bruckner, D.</creatorcontrib><creatorcontrib>Schroedl, F.</creatorcontrib><creatorcontrib>Bogner, B.</creatorcontrib><creatorcontrib>Kaser-Eichberger, A.</creatorcontrib><creatorcontrib>Runge, C.</creatorcontrib><creatorcontrib>Strohmaier, C.</creatorcontrib><creatorcontrib>Klein, B.</creatorcontrib><creatorcontrib>Aigner, L.</creatorcontrib><creatorcontrib>Reitsamer, H.A.</creatorcontrib><title>Time-dependent retinal ganglion cell loss, microglial activation and blood-retina-barrier tightness in an acute model of ocular hypertension</title><title>Experimental eye research</title><addtitle>Exp Eye Res</addtitle><description>Glaucoma is a group of neurodegenerative diseases characterized by the progressive loss of retinal ganglion cells (RGCs) and their axons, and is the second leading cause of blindness worldwide. Elevated intraocular pressure is a well known risk factor for the development of glaucomatous optic neuropathy and pharmacological or surgical lowering of intraocular pressure represents a standard procedure in glaucoma treatment. However, the treatment options are limited and although lowering of intraocular pressure impedes disease progression, glaucoma cannot be cured by the currently available therapy concepts. In an acute short-term ocular hypertension model in rat, we characterize RGC loss, but also microglial cell activation and vascular alterations of the retina at certain time points. The combination of these three parameters might facilitate a better evaluation of the disease progression, and could further serve as a new model to test novel treatment strategies at certain time points. Acute ocular hypertension (OHT) was induced by the injection of magnetic microbeads into the rat anterior chamber angle (n = 22) with magnetic position control, leading to constant elevation of IOP. At certain time points post injection (4d, 7d, 10d, 14d and 21d), RGC loss, microglial activation, and microvascular pericyte (PC) coverage was analyzed using immunohistochemistry with corresponding specific markers (Brn3a, Iba1, NG2). Additionally, the tightness of the retinal vasculature was determined via injections of Texas Red labeled dextran (10 kDa) and subsequently analyzed for vascular leakage. For documentation, confocal laser-scanning microscopy was used, followed by cell counts, capillary length measurements and morphological and statistical analysis. The injection of magnetic microbeads led to a progressive loss of RGCs at the five time points investigated (20.07%, 29.52%, 41.80%, 61.40% and 76.57%). Microglial cells increased in number and displayed an activated morphology, as revealed by Iba1-positive cell number (150.23%, 175%, 429.25%,486.72% and 544.78%) and particle size analysis (205.49%, 203.37%, 412.84%, 333.37% and 299.77%) compared to contralateral control eyes. Pericyte coverage (NG2-positive PC/mm) displayed a significant reduction after 7d of OHT in central, and after 7d and 10d in peripheral retina. Despite these alterations, the tightness of the retinal vasculature remained unaltered at 14 and 21 days after OHT induction. While vascular tightness was unchanged in the course of OHT, a progressive loss of RGCs and activation of microglial cells was detected. Since a significant loss in RGCs was observed already at day 4 of experimental glaucoma, and since activated microglia peaked at day 10, we determined a time frame of 7–14 days after MB injection as potential optimum to study glaucoma mechanisms in this model. •Chronological pathological changes in an acute model of ocular hypertension.•Evaluation of RGC degeneration and microglial activation at 5 time points.•Evaluation of retinal vascular alterations in the course of MB-induced OHT.•Definition of an optimal time frame (7–14d) to employ experimental interventions.</description><subject>Acute Disease</subject><subject>Animals</subject><subject>Antigens - metabolism</subject><subject>Biomarkers - metabolism</subject><subject>Blood-Retinal Barrier - metabolism</subject><subject>Blood-Retinal Barrier - pathology</subject><subject>Calcium-Binding Proteins - metabolism</subject><subject>Disease Models, Animal</subject><subject>Experimental glaucoma</subject><subject>Female</subject><subject>Fluorescent Antibody Technique, Indirect</subject><subject>Intraocular Pressure</subject><subject>Male</subject><subject>Microfilament Proteins - metabolism</subject><subject>Microglia</subject><subject>Microglia - metabolism</subject><subject>Microglia - pathology</subject><subject>Microscopy, Confocal</subject><subject>Ocular hypertension</subject><subject>Ocular Hypertension - etiology</subject><subject>Ocular Hypertension - metabolism</subject><subject>Ocular Hypertension - pathology</subject><subject>Pericytes</subject><subject>Proteoglycans - metabolism</subject><subject>Rats</subject><subject>Rats, Inbred BN</subject><subject>Real-Time Polymerase Chain Reaction</subject><subject>Retinal ganglion cells</subject><subject>Retinal Ganglion Cells - metabolism</subject><subject>Retinal Ganglion Cells - pathology</subject><subject>Time Factors</subject><subject>Transcription Factor Brn-3A - metabolism</subject><issn>0014-4835</issn><issn>1096-0007</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UctqHDEQFCEhXjv5gRyCjjl41tKMpNkBX4LxCwy-OGehkVprLRppI2mM_Q_-6GhYO0dDQ0N3VUFVIfSDkjUlVJzt1vAMad0SytekDiWf0IqSQTSEkP4zWhFCWcM2HT9Cxznv6rVjPfuKjlpRX7wVK_T64CZoDOwhGAgFJyguKI-3Kmy9iwFr8B77mPMpnpxOsV7rW-ninlRZACoYPPoYTXPgNqNKyUHCxW0fS4CcsVtQlTMXwFM04HG0OOrZq4QfX_aQCoRctb6hL1b5DN_f9gn6c3X5cHHT3N1f3178vmt0x0VpuB0EFWCYHSznnFg6KGO5tazVamAd9DD0PbVWKGXJOFhFdWvqjYEd2abvTtCvg-4-xb8z5CInlxejKkCcs6Ris6lZ9ZRWaHuAVus5J7Byn9yk0oukRC4tyJ1cWpBLC5LUoaSSfr7pz-ME5j_lPfYKOD8AoLp8qmHJrB0EDcYl0EWa6D7S_wc0mZyq</recordid><startdate>201507</startdate><enddate>201507</enddate><creator>Trost, A.</creator><creator>Motloch, K.</creator><creator>Bruckner, D.</creator><creator>Schroedl, F.</creator><creator>Bogner, B.</creator><creator>Kaser-Eichberger, A.</creator><creator>Runge, C.</creator><creator>Strohmaier, C.</creator><creator>Klein, B.</creator><creator>Aigner, L.</creator><creator>Reitsamer, H.A.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201507</creationdate><title>Time-dependent retinal ganglion cell loss, microglial activation and blood-retina-barrier tightness in an acute model of ocular hypertension</title><author>Trost, A. ; Motloch, K. ; Bruckner, D. ; Schroedl, F. ; Bogner, B. ; Kaser-Eichberger, A. ; Runge, C. ; Strohmaier, C. ; Klein, B. ; Aigner, L. ; Reitsamer, H.A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-5f9616ed4f9f5550f19adf5ff42ca943e7e9771ff6aaf0b9fa1c2de974efb4873</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Acute Disease</topic><topic>Animals</topic><topic>Antigens - metabolism</topic><topic>Biomarkers - metabolism</topic><topic>Blood-Retinal Barrier - metabolism</topic><topic>Blood-Retinal Barrier - pathology</topic><topic>Calcium-Binding Proteins - metabolism</topic><topic>Disease Models, Animal</topic><topic>Experimental glaucoma</topic><topic>Female</topic><topic>Fluorescent Antibody Technique, Indirect</topic><topic>Intraocular Pressure</topic><topic>Male</topic><topic>Microfilament Proteins - metabolism</topic><topic>Microglia</topic><topic>Microglia - metabolism</topic><topic>Microglia - pathology</topic><topic>Microscopy, Confocal</topic><topic>Ocular hypertension</topic><topic>Ocular Hypertension - etiology</topic><topic>Ocular Hypertension - metabolism</topic><topic>Ocular Hypertension - pathology</topic><topic>Pericytes</topic><topic>Proteoglycans - metabolism</topic><topic>Rats</topic><topic>Rats, Inbred BN</topic><topic>Real-Time Polymerase Chain Reaction</topic><topic>Retinal ganglion cells</topic><topic>Retinal Ganglion Cells - metabolism</topic><topic>Retinal Ganglion Cells - pathology</topic><topic>Time Factors</topic><topic>Transcription Factor Brn-3A - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Trost, A.</creatorcontrib><creatorcontrib>Motloch, K.</creatorcontrib><creatorcontrib>Bruckner, D.</creatorcontrib><creatorcontrib>Schroedl, F.</creatorcontrib><creatorcontrib>Bogner, B.</creatorcontrib><creatorcontrib>Kaser-Eichberger, A.</creatorcontrib><creatorcontrib>Runge, C.</creatorcontrib><creatorcontrib>Strohmaier, C.</creatorcontrib><creatorcontrib>Klein, B.</creatorcontrib><creatorcontrib>Aigner, L.</creatorcontrib><creatorcontrib>Reitsamer, H.A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Experimental eye research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Trost, A.</au><au>Motloch, K.</au><au>Bruckner, D.</au><au>Schroedl, F.</au><au>Bogner, B.</au><au>Kaser-Eichberger, A.</au><au>Runge, C.</au><au>Strohmaier, C.</au><au>Klein, B.</au><au>Aigner, L.</au><au>Reitsamer, H.A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Time-dependent retinal ganglion cell loss, microglial activation and blood-retina-barrier tightness in an acute model of ocular hypertension</atitle><jtitle>Experimental eye research</jtitle><addtitle>Exp Eye Res</addtitle><date>2015-07</date><risdate>2015</risdate><volume>136</volume><spage>59</spage><epage>71</epage><pages>59-71</pages><issn>0014-4835</issn><eissn>1096-0007</eissn><abstract>Glaucoma is a group of neurodegenerative diseases characterized by the progressive loss of retinal ganglion cells (RGCs) and their axons, and is the second leading cause of blindness worldwide. Elevated intraocular pressure is a well known risk factor for the development of glaucomatous optic neuropathy and pharmacological or surgical lowering of intraocular pressure represents a standard procedure in glaucoma treatment. However, the treatment options are limited and although lowering of intraocular pressure impedes disease progression, glaucoma cannot be cured by the currently available therapy concepts. In an acute short-term ocular hypertension model in rat, we characterize RGC loss, but also microglial cell activation and vascular alterations of the retina at certain time points. The combination of these three parameters might facilitate a better evaluation of the disease progression, and could further serve as a new model to test novel treatment strategies at certain time points. Acute ocular hypertension (OHT) was induced by the injection of magnetic microbeads into the rat anterior chamber angle (n = 22) with magnetic position control, leading to constant elevation of IOP. At certain time points post injection (4d, 7d, 10d, 14d and 21d), RGC loss, microglial activation, and microvascular pericyte (PC) coverage was analyzed using immunohistochemistry with corresponding specific markers (Brn3a, Iba1, NG2). Additionally, the tightness of the retinal vasculature was determined via injections of Texas Red labeled dextran (10 kDa) and subsequently analyzed for vascular leakage. For documentation, confocal laser-scanning microscopy was used, followed by cell counts, capillary length measurements and morphological and statistical analysis. The injection of magnetic microbeads led to a progressive loss of RGCs at the five time points investigated (20.07%, 29.52%, 41.80%, 61.40% and 76.57%). Microglial cells increased in number and displayed an activated morphology, as revealed by Iba1-positive cell number (150.23%, 175%, 429.25%,486.72% and 544.78%) and particle size analysis (205.49%, 203.37%, 412.84%, 333.37% and 299.77%) compared to contralateral control eyes. Pericyte coverage (NG2-positive PC/mm) displayed a significant reduction after 7d of OHT in central, and after 7d and 10d in peripheral retina. Despite these alterations, the tightness of the retinal vasculature remained unaltered at 14 and 21 days after OHT induction. While vascular tightness was unchanged in the course of OHT, a progressive loss of RGCs and activation of microglial cells was detected. Since a significant loss in RGCs was observed already at day 4 of experimental glaucoma, and since activated microglia peaked at day 10, we determined a time frame of 7–14 days after MB injection as potential optimum to study glaucoma mechanisms in this model. •Chronological pathological changes in an acute model of ocular hypertension.•Evaluation of RGC degeneration and microglial activation at 5 time points.•Evaluation of retinal vascular alterations in the course of MB-induced OHT.•Definition of an optimal time frame (7–14d) to employ experimental interventions.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>26001526</pmid><doi>10.1016/j.exer.2015.05.010</doi><tpages>13</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0014-4835
ispartof Experimental eye research, 2015-07, Vol.136, p.59-71
issn 0014-4835
1096-0007
language eng
recordid cdi_proquest_miscellaneous_1688003711
source MEDLINE; Elsevier ScienceDirect Journals
subjects Acute Disease
Animals
Antigens - metabolism
Biomarkers - metabolism
Blood-Retinal Barrier - metabolism
Blood-Retinal Barrier - pathology
Calcium-Binding Proteins - metabolism
Disease Models, Animal
Experimental glaucoma
Female
Fluorescent Antibody Technique, Indirect
Intraocular Pressure
Male
Microfilament Proteins - metabolism
Microglia
Microglia - metabolism
Microglia - pathology
Microscopy, Confocal
Ocular hypertension
Ocular Hypertension - etiology
Ocular Hypertension - metabolism
Ocular Hypertension - pathology
Pericytes
Proteoglycans - metabolism
Rats
Rats, Inbred BN
Real-Time Polymerase Chain Reaction
Retinal ganglion cells
Retinal Ganglion Cells - metabolism
Retinal Ganglion Cells - pathology
Time Factors
Transcription Factor Brn-3A - metabolism
title Time-dependent retinal ganglion cell loss, microglial activation and blood-retina-barrier tightness in an acute model of ocular hypertension
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T20%3A34%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Time-dependent%20retinal%20ganglion%20cell%20loss,%20microglial%20activation%20and%20blood-retina-barrier%20tightness%20in%20an%20acute%20model%20of%20ocular%20hypertension&rft.jtitle=Experimental%20eye%20research&rft.au=Trost,%20A.&rft.date=2015-07&rft.volume=136&rft.spage=59&rft.epage=71&rft.pages=59-71&rft.issn=0014-4835&rft.eissn=1096-0007&rft_id=info:doi/10.1016/j.exer.2015.05.010&rft_dat=%3Cproquest_cross%3E1688003711%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1688003711&rft_id=info:pmid/26001526&rft_els_id=S001448351500158X&rfr_iscdi=true